These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 15255413)

  • 21. Helicobacter pylori-negative nonsteroidal anti-inflammatory drug-negative ulcer.
    McColl KE
    Gastroenterol Clin North Am; 2009 Jun; 38(2):353-61. PubMed ID: 19446263
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Meta-analysis: role of Helicobacter pylori eradication in the prevention of peptic ulcer in NSAID users.
    Vergara M; Catalán M; Gisbert JP; Calvet X
    Aliment Pharmacol Ther; 2005 Jun; 21(12):1411-8. PubMed ID: 15948807
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Pathogen eradication prevents gastrointestinal complications].
    MMW Fortschr Med; 2007 Oct; 149(43):58-9. PubMed ID: 17992910
    [No Abstract]   [Full Text] [Related]  

  • 24. Non-steroidal anti-inflammatory drug-induced gastroduodenal toxicity and Helicobacter pylori.
    Wardi J; Shirin H
    Isr Med Assoc J; 2003 Mar; 5(3):195-7. PubMed ID: 12725142
    [No Abstract]   [Full Text] [Related]  

  • 25. Safer NSAID strategies: consensus or contentious?
    Hawkey CJ
    Rheumatology (Oxford); 2008 Sep; 47(9):1265-6. PubMed ID: 18611921
    [No Abstract]   [Full Text] [Related]  

  • 26. [Peptic ulcer, NSAID and Helicobacter].
    Abdo-Francis JM
    Rev Gastroenterol Mex; 2013 Aug; 78 Suppl 1():8-9. PubMed ID: 24041043
    [No Abstract]   [Full Text] [Related]  

  • 27. Helicobacter pylori and non-malignant diseases.
    Matysiak-Budnik T; Laszewicz W; Lamarque D; Chaussade S
    Helicobacter; 2006 Oct; 11 Suppl 1():27-31. PubMed ID: 16925608
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The role of psychosocial factors in peptic ulcer disease: beyond Helicobacter pylori and NSAIDs.
    Jones MP
    J Psychosom Res; 2006 Apr; 60(4):407-12. PubMed ID: 16581366
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Helicobacter pylori and non-steroidal anti-inflammatory drugs: uncomfortable partners in peptic ulcer disease.
    Taha AS; Russell RI
    Gut; 1993 May; 34(5):580-3. PubMed ID: 8504954
    [No Abstract]   [Full Text] [Related]  

  • 30. Factors predisposing to peptic ulcer disease in asymptomatic cirrhotic patients.
    Kamalaporn P; Sobhonslidsuk A; Jatchavala J; Atisook K; Rattanasiri S; Pramoolsinsap C
    Aliment Pharmacol Ther; 2005 Jun; 21(12):1459-65. PubMed ID: 15948813
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Acid-related diseases. Should H. pylori be eradicated in patients who will receive prolonged NSAID treatment?].
    Lanas Arbeloa A
    Gastroenterol Hepatol; 2009 Mar; 32(3):173-4. PubMed ID: 19268192
    [No Abstract]   [Full Text] [Related]  

  • 32. Non-steroidal anti-inflammatory drugs (NSAID) cause gastrointestinal ulcers mainly in Helicobacter pylori carriers.
    Neustater BR; Barkin JS
    Gastrointest Endosc; 1995 Feb; 41(2):186-7. PubMed ID: 7721023
    [No Abstract]   [Full Text] [Related]  

  • 33. Interaction of nonsteroidal anti-inflammatory drugs (NSAID) with Helicobacter pylori in the stomach of humans and experimental animals.
    Brzozowski T; Konturek PC; Sliwowski Z; Kwiecień S; Drozdowicz D; Pawlik M; Mach K; Konturek SJ; Pawlik WW
    J Physiol Pharmacol; 2006 Sep; 57 Suppl 3():67-79. PubMed ID: 17033106
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Cyclooxygenase-2 and gastroduodenal lesions. Any relationship with Helicobacter pylori ? A systematic review].
    Gisbert JP; Pajares JM
    Med Clin (Barc); 2003 Apr; 120(14):550-8. PubMed ID: 12724068
    [No Abstract]   [Full Text] [Related]  

  • 35. [Adverse effects of NSAIDs in treatment of rheumatoid arthritis].
    Kato M; Takeda H; Asaka M
    Nihon Rinsho; 2005 Jan; 63 Suppl 1():560-5. PubMed ID: 15799418
    [No Abstract]   [Full Text] [Related]  

  • 36. Dosage in ulcer study.
    Bobrove AM
    Hosp Pract (1995); 1998 Jun; 33(6):46. PubMed ID: 9636350
    [No Abstract]   [Full Text] [Related]  

  • 37. [Peptic ulcer and its treatment modalities in medicine].
    De Miranda AC
    Acta Med Port; 1998 Jan; 11(1):77-9. PubMed ID: 9542182
    [No Abstract]   [Full Text] [Related]  

  • 38. Management issues for debate: the problems in perspective.
    O'Donnell M; Alexander-Williams J; Heatley RV; Pounder RE; Wormsley KG
    Aliment Pharmacol Ther; 1993; 7 Suppl 2():49-55. PubMed ID: 8364142
    [No Abstract]   [Full Text] [Related]  

  • 39. [Peptic ulcer: control of pH and/or eradication of Helicobacter pylori].
    Bosques Padilla F
    Rev Gastroenterol Mex; 1996; 61(4 Suppl 2):S25-9. PubMed ID: 9102771
    [No Abstract]   [Full Text] [Related]  

  • 40. [Acute ulcer disease: diagnosis, therapy, complications, indications for surgery].
    Halter F
    Schweiz Med Wochenschr; 1994 Mar; 124(10):421-5. PubMed ID: 8153601
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.